
Meclizine Tablet
Form: Tablets
Strength: 25 mg
Reference Brands: Antivert, Bonine, Dramamine(US)
Category: Antiemetic
Meclizine tablets, marketed as Antivert and branded generics, are approved in the US by the FDA and in the EU via EMA for motion sickness, vertigo, and nausea. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports swift approval, safe usage, and global availability, helping patients worldwide manage vestibular issues and nausea effectively for improved safety and comfort.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Scopolamine (Hyoscine) Transdermal Patches
Strength: 1.5 mg
Form: Transdermal patch
Reference Brands: Transderm-Scop(US)
View DetailsDimenhydrinate Tablets
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Dramamine(US & EU)
View DetailsCyclizine Tablet
Strength: 50 mg
Form: Tablets
Reference Brands: Marezine, Cyclivert, and Bonine(US)
View DetailsNetupitant + Palonosetron Capsules
Strength: 300 mg netupitant and 0.5 mg palonosetron
Form: Capsules
Reference Brands: Akynzeo(US & EU)
View Details